United States
Germany
Japan
United Kingdom
China
Products
Rabbit Polyclonal MEK1/2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal MEK1/2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal MEK1/2 (Ser217) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho-specific |
Rabbit Polyclonal MEK1/2 (Ser221) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho-specific |
Rabbit Polyclonal MEK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal MEK1 (Thr291) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho-specific |
CNY 5,973.00
5周
MEK1 (MAP2K1) (incl. pos. control) mouse monoclonal antibody, clone 9G3, Purified
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1C1 (formerly 1C1)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Reactivities
Applications
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Pathways
- Acute myeloid leukemia (235)
- B cell receptor signaling pathway (235)
- Bladder cancer (235)
- Chemokine signaling pathway (235)
- Chronic myeloid leukemia (235)
- Colorectal cancer (235)
- Dorso-ventral axis formation (235)
- Endometrial cancer (235)
- ErbB signaling pathway (235)
- Fc epsilon RI signaling pathway (235)
- Fc gamma R-mediated phagocytosis (235)
- Focal adhesion (235)
- Gap junction (235)
- Glioma (235)
- GnRH signaling pathway (235)
- Insulin signaling pathway (235)
- Long-term depression (235)
- Long-term potentiation (235)
- MAPK signaling pathway (235)
- Melanogenesis (235)
- Melanoma (235)
- Natural killer cell mediated cytotoxicity (235)
- Neurotrophin signaling pathway (235)
- Non-small cell lung cancer (235)
- Oocyte meiosis (235)
- Pancreatic cancer (235)
- Pathways in cancer (235)
- Prion diseases (235)
- Progesterone-mediated oocyte maturation (235)
- Prostate cancer (235)
- Regulation of actin cytoskeleton (235)
- Renal cell carcinoma (235)
- T cell receptor signaling pathway (235)
- Thyroid cancer (235)
- Toll-like receptor signaling pathway (235)
- VEGF signaling pathway (235)
- Vascular smooth muscle contraction (235)
